Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rommer

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Therapeutic Advances in Neurological Disorders|May 15, 2026
Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and SwitzerlandAchim Berthele, Orhan Aktas, Ilya Ayzenberg, et al.
Annals of Clinical and Translational Neurology|December 17, 2024
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical thresholdGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 7, 2024
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining conceptGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Acta Neuropathologica|September 16, 2023
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosisAnnika Hofmann, Nik Krajnc, Assunta Dal-Bianco, et al.
European Journal of Neurology|December 28, 2020
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC scoreGabriel Bsteh, Harald Hegen, Katharina Riedl, et al.
Journal of Neurology|June 9, 2026
Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosisFabian Föttinger, Nik Krajnc, Klaus Berek, et al.
Annals of Neurology|January 24, 2022
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic PatientsBarbara Kornek, Fritz Leutmezer, Paulus S Rommer, et al.
Annals of Neurology|September 25, 2021
Neuropathological Variability within a Spectrum of NMDAR-EncephalitisTobias Zrzavy, Verena Endmayr, Jan Bauer, et al.
Annals of Clinical and Translational Neurology|August 5, 2025
The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple SclerosisGabriel Bsteh, Ruchi Tanavade, Nik Krajnc, et al.
Acta Neuropathologica Communications|April 16, 2020
Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopesIrina Tsymala, Magdalini Nigritinou, Bleranda Zeka, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Therapeutic Advances in Neurological Disorders|May 15, 2026
Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and SwitzerlandAchim Berthele, Orhan Aktas, Ilya Ayzenberg, et al.
Annals of Clinical and Translational Neurology|December 17, 2024
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical thresholdGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 7, 2024
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining conceptGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Acta Neuropathologica|September 16, 2023
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosisAnnika Hofmann, Nik Krajnc, Assunta Dal-Bianco, et al.
European Journal of Neurology|December 28, 2020
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC scoreGabriel Bsteh, Harald Hegen, Katharina Riedl, et al.
Journal of Neurology|June 9, 2026
Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosisFabian Föttinger, Nik Krajnc, Klaus Berek, et al.
Annals of Neurology|January 24, 2022
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic PatientsBarbara Kornek, Fritz Leutmezer, Paulus S Rommer, et al.
Annals of Neurology|September 25, 2021
Neuropathological Variability within a Spectrum of NMDAR-EncephalitisTobias Zrzavy, Verena Endmayr, Jan Bauer, et al.
Annals of Clinical and Translational Neurology|August 5, 2025
The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple SclerosisGabriel Bsteh, Ruchi Tanavade, Nik Krajnc, et al.
Acta Neuropathologica Communications|April 16, 2020
Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopesIrina Tsymala, Magdalini Nigritinou, Bleranda Zeka, et al.
Pageof 22